Karl‐Heinz Heider - Concepedia

Author

Karl‐Heinz Heider

Also Known As

B. Opitz, K H Heider, K Heider, K. H. Heider, K. Heider, K.-H. Heider, K.H. Heider, Karl-Heinz Heider, Karl‐Heinz Heider

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Boehringer Ingelheim (Austria)Boehringer Ingelheim (Germany)FZI Research Center for Information Technology University of Vienna University of Amsterdam

About

Karl‐Heinz Heider is an author at Boehringer Ingelheim (Austria) specializing in medicine, tumor biology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	2.1K
2	Cell Biology	7	7	1.7K
3	Engineering	1	1	15
4	Biomedical Engineering	1	1	15
5	Biomolecular Engineering	1	1	15

Karl‐Heinz Heider

Publications

3.1K

Citations

H-Index

Page 1

	Year	Citations
Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. VJM Wielenga, Karl‐Heinz Heider, G.J.A. Offerhaus, PubMed Cd44 GlycoproteinMedicineCd44 Variant ProteinsPathologyColorectal Cancer	1993	532
Polycation-based DNA complexes for tumor-targeted gene deliveryin vivo Ralf Kircheis, Susanne Schüller, Sylvia Brunner, The Journal of Gene Medicine	1999	353
A human homologue of the rat metastasis-associated variant of CD44 is expressed in colorectal carcinomas and adenomatous polyps. Karl‐Heinz Heider, E Hors, Femke van den Berg, The Journal of Cell Biology Tumor BiologyCd44 Variant ExpressionMalignant DiseaseMedicineSplice Variant	1993	349
Activated human lymphocytes and aggressive non-Hodgkin's lymphomas express a homologue of the rat metastasis-associated variant of CD44. Gerrit Koopman, Karl‐Heinz Heider, E Horst, The Journal of Experimental Medicine Lymphoid NeoplasiaExon V6Aggressive Non-hodgkinImmunologyTumor Immunity	1993	305
Tissue-Wide Expression Profiling Using cDNA Subtraction and Microarrays to Identify Tumor-Specific Genes Stefan Amatschek, Ulrich Koenig, Herbert Auer, Cancer Research	2004	232
The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior. W. Rudy, R Schwartz-Albiez, Margot Zöller, PubMed Spontaneous Metastasis ProtocolTumor BiologyPancreatic CancerMetastatic BehaviorMajor Cd44 Proteins	1993	220
Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Karl‐Heinz Heider, J Dämmrich, Petra Skroch-Angel, PubMed Esophageal CancerImmunologyGastroenterologyPathologyNormal Gastric Mucosa	1993	203
Comparison of immunohistochemistry and RT‐PCR for detection of CD44v‐expression, a new prognostic factor in human breast cancer Peter Dall, Karl‐Heinz Heider, Hans‐Peter Sinn, International Journal of Cancer	1995	148
Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium. Peter Dall, Karl‐Heinz Heider, Armin Hekele, PubMed ImmunologyPathologyUterine Cervical CancerCancer BiologyTumor Biology	1994	124
A novel Fc-engineered monoclonal antibody to CD37 with enhanced ADCC and high proapoptotic activity for treatment of B-cell malignancies Karl‐Heinz Heider, Kerstin Kiefer, Thorsten Zenz, Blood	2011	103

Page 1